GO:0097190 apoptotic signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097190 apoptotic signaling pathway describes the molecular signal reception and relay steps that commit a cell to programmed death, ending when the execution phase of apoptosis is triggered.
• The pathway includes both extrinsic (death receptor) and intrinsic (mitochondrial) arms, with crosstalk mediated by BH3-only proteins and caspase activation.
• Dysregulation of apoptotic signaling contributes to cancer, neurodegeneration, autoimmune disease, and developmental disorders.
• Key regulators include caspases, BCL-2 family proteins, death receptors (FAS, TNFRSF10A/B), and adaptors such as FADD and TRADD.
• Environmental toxins and inflammatory signals can potentiate or suppress apoptotic signaling through MAPK, NF-kB, and JAK/STAT pathways.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of apoptotic signaling components in disease contexts.
Description
The apoptotic signaling pathway (GO:0097190) is the series of molecular events that begins with reception of a death-inducing signal and culminates in activation of the execution phase of apoptosis. This process is essential for normal development, tissue homeostasis, and immune surveillance, and its dysregulation underlies numerous human diseases. The pathway encompasses extrinsic signaling through death receptors such as FAS and TNFRSF10A/B, as well as intrinsic mitochondrial signaling, with extensive crosstalk that determines cell fate. Understanding the precise molecular steps of apoptotic signaling is critical for identifying therapeutic targets in cancer, neurodegeneration, and inflammatory disorders. Researchers study this pathway using genetic models, biochemical assays, and high-throughput screening to map the signaling network and its regulatory nodes.
apoptotic signaling pathway At A Glance
| GO ID | GO:0097190 |
|---|---|
| GO term | apoptotic signaling pathway |
| Ontology | biological_process |
| Synonym | apoptotic signalling pathway; induction of apoptosis by extracellular signals |
| Major function | Reception and relay of death-inducing signals that commit a cell to apoptosis |
| Subprocesses | Extrinsic apoptotic signaling pathway; intrinsic apoptotic signaling pathway; caspase activation |
| Key regulators | Caspases, BCL-2 family proteins, death receptors, adaptor proteins |
| Disease relevance | Cancer, neurodegeneration, autoimmune disease, developmental disorders |
What Is GO:0097190?
GO:0097190 apoptotic signaling pathway is defined as the series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. It includes both extrinsic apoptotic signaling pathway (death receptor-mediated) and intrinsic apoptotic signaling pathway (mitochondrial), as well as the signaling events that connect them.
Why Is apoptotic signaling pathway Important in Cell Biology?
Apoptotic signaling is a fundamental biological process that maintains tissue homeostasis and protects against malignant transformation. Its dysregulation is a hallmark of cancer, where cancer cells evade apoptosis, and of neurodegenerative diseases, where excessive apoptosis contributes to neuronal loss. The pathway is also a major target for therapeutic intervention, with drugs designed to modulate death receptor signaling or BCL-2 family activity. Understanding the molecular mechanisms of apoptotic signaling is therefore essential for developing targeted therapies and for interpreting disease-associated genetic variants.
• Maintains tissue homeostasis by eliminating damaged or superfluous cells.
• Plays a central role in immune surveillance and elimination of infected cells.
• Dysregulation leads to cancer, as cancer cells often evade apoptosis.
• Excessive apoptotic signaling contributes to neurodegeneration and ischemic injury.
• Modulates inflammatory responses through crosstalk with NF-kB and MAPK pathways.
• Serves as a target for chemotherapeutic and targeted agents.
• Involved in erythropoiesis and blood disorders such as beta-thalassemia.
• Environmental toxins can potentiate apoptotic signaling in the brain.
• Apoptotic cell clearance by phagocytes is primed by signaling events.
• CRISPR screens identify novel regulators of apoptotic signaling.
What Happens During apoptotic signaling pathway?
Signal Reception at the Plasma Membrane
In simple terms: A death signal binds to a receptor on the cell surface, like a key fitting a lock.
The extrinsic apoptotic signaling pathway is initiated when extracellular ligands such as FASLG or TRAIL bind to death receptors including FAS (CD95) and TNFRSF10A/B (DR4/DR5). This binding induces receptor trimerization and recruitment of adaptor proteins such as FADD, which in turn recruit procaspase-8 or -10 to form the death-inducing signaling complex (DISC). This step represents the reception of the apoptotic signal as defined in GO:0097190.
Caspase Activation and the Execution Phase
In simple terms: The signal activates a chain of molecular scissors that dismantle the cell.
At the DISC, procaspase-8 is activated and can directly cleave effector caspases-3 and -7, or cleave the BH3-only protein BID to engage the mitochondrial pathway. Effector caspases then cleave hundreds of substrates, leading to the morphological and biochemical hallmarks of apoptosis. This execution phase marks the endpoint of GO:0097190.
Mitochondrial Outer Membrane Permeabilization (Intrinsic Arm)
In simple terms: The mitochondria release factors that amplify the death signal.
The intrinsic apoptotic signaling pathway is triggered by cellular stress and involves BAX/BAK-mediated mitochondrial outer membrane permeabilization (MOMP), releasing cytochrome c and SMAC/DIABLO. Cytochrome c binds APAF1 to form the apoptosome, which activates caspase-9, which in turn activates effector caspases. This arm is interconnected with the extrinsic pathway through BID cleavage.
Regulation by BCL-2 Family Proteins
In simple terms: A family of proteins acts as a balance to decide whether the cell lives or dies.
The BCL-2 family includes anti-apoptotic proteins (BCL-2, BCL-XL, MCL-1), pro-apoptotic effectors (BAX, BAK), and BH3-only sensitizers (BID, BIM, PUMA, NOXA). The balance between these proteins determines whether MOMP occurs. BH3-only proteins are regulated transcriptionally and post-translationally by survival signaling pathways.
Crosstalk with Other Signaling Pathways
In simple terms: Other cellular signals can either boost or block the death signal.
Apoptotic signaling is modulated by MAPK, NF-kB, JAK/STAT, and PI3K/AKT pathways. For example, IL-33 neutralization regulates NF-kB/STAT3/SOCS3 signaling to reduce apoptosis in septic myocardial injury. Cadmium exposure potentiates apoptotic signaling in the striatum and hippocampus through oxidative stress and MAPK activation. Chito-oligosaccharide attenuates LPS-induced intestinal inflammation by regulating mitochondrial apoptotic and MAPK signaling.
Key Genes Involved in GO:0097190 apoptotic signaling pathway
The following genes encode core components and regulators of the apoptotic signaling pathway (GO:0097190) that are frequently studied in disease and drug discovery research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FAS | Death receptor that triggers extrinsic apoptosis upon FASLG binding | Autoimmune lymphoproliferative syndrome; cancer immune evasion |
| FASLG | Ligand for FAS; induces receptor trimerization and DISC formation | Target for cancer immunotherapy |
| TNFRSF10A | Death receptor 4 (DR4) for TRAIL; activates extrinsic apoptosis | Cancer therapy target |
| TNFRSF10B | Death receptor 5 (DR5) for TRAIL; activates extrinsic apoptosis | Cancer therapy target |
| FADD | Adaptor protein recruiting caspase-8 to death receptors | Essential for extrinsic apoptosis; knockout models |
| CASP8 | Initiator caspase activated at the DISC | Mutations linked to immune disorders and cancer |
| CASP3 | Effector caspase executing apoptosis | Central executioner; knockout models |
| CASP9 | Initiator caspase activated by apoptosome | Intrinsic apoptosis; knockout models |
| BCL2 | Anti-apoptotic protein inhibiting MOMP | Overexpressed in follicular lymphoma |
| BAX | Pro-apoptotic effector mediating MOMP | Knockout models show resistance to apoptosis |
| BAK | Pro-apoptotic effector mediating MOMP | Redundant with BAX |
| BID | BH3-only protein linking extrinsic and intrinsic pathways | Cleaved by caspase-8; key crosstalk node |
| TP53 | Transcription factor inducing PUMA, NOXA, and BAX | Mutated in >50% of cancers |
| MAPK1 | Kinase modulating apoptotic signaling in response to stress | Involved in cadmium-induced apoptosis |
| STAT3 | Transcription factor regulating anti-apoptotic genes | Modulated by IL-33 in septic myocardial injury |
| NFKB1 | Transcription factor controlling survival and apoptotic genes | Crosstalk with apoptotic signaling |
| JAK2 | Kinase upstream of STAT3; modulates apoptosis | Target in neuroinflammation |
How Is apoptotic signaling pathway Regulated?
Apoptotic signaling is tightly regulated at multiple levels. Transcriptional regulation by p53 induces pro-apoptotic BH3-only proteins such as PUMA and NOXA. Post-translational modifications, including phosphorylation and ubiquitination, control the stability and activity of BCL-2 family proteins and caspases. E3 ubiquitin ligases and deubiquitinases modulate TRAIL-mediated extrinsic apoptotic signaling by targeting components of the DISC and downstream effectors. Survival signaling through PI3K/AKT, NF-kB, and JAK/STAT pathways can suppress apoptotic signaling by upregulating anti-apoptotic proteins. Additionally, microRNAs such as miR-204-5p can influence apoptotic signaling indirectly through JAK2/STAT3 modulation.
apoptotic signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL2 | Follicular lymphoma; apoptosis evasion | Overexpression in B-cell lines; BH3 mimetic sensitivity |
| TP53 | Li-Fraumeni syndrome; cancer predisposition | Knockout and point-mutation (R175H) in cancer cell lines |
| FAS | Autoimmune lymphoproliferative syndrome | Knockout mice; patient-derived lymphoblasts |
| CASP8 | Immunodeficiency and cancer susceptibility | Knockout and point-mutation models |
| STAT3 | Septic myocardial injury; inflammation | Knockout and overexpression in cardiomyocytes |
Apoptotic Signaling in Cancer
Cancer cells frequently evade apoptosis by overexpressing anti-apoptotic proteins (e.g., BCL-2) or mutating pro-apoptotic effectors (e.g., BAX). Defects in death receptor signaling, such as loss of FAS or TRAIL receptor expression, contribute to immune evasion. Targeting apoptotic signaling with BH3 mimetics or TRAIL receptor agonists is a major therapeutic strategy.
Apoptotic Signaling in Neurodegeneration
Excessive apoptotic signaling contributes to neuronal loss in neurodegenerative diseases and acute brain injury. Chronic exposure to environmental toxins such as cadmium potentiates apoptotic signaling in the striatum and hippocampus, leading to neurobehavioral impairment. Modulating apoptotic signaling is therefore a potential neuroprotective strategy.
Apoptotic Signaling in Inflammatory and Metabolic Disorders
Apoptotic signaling is intertwined with inflammatory pathways. In septic myocardial injury, neutralization of IL-33 reduces apoptosis through regulation of NF-kB/STAT3/SOCS3 signaling. Dietary chito-oligosaccharide attenuates LPS-challenged intestinal inflammation by regulating mitochondrial apoptotic and MAPK signaling. These findings highlight the therapeutic potential of targeting apoptotic signaling in inflammatory diseases.
Apoptotic Signaling in Hematological Disorders
The extrinsic apoptotic signaling pathway plays a role in definitive erythropoiesis, and its dysregulation is observed in patients with beta-thalassemia. Understanding how apoptotic signaling affects erythroid differentiation may provide insights into anemia treatment.
From apoptotic signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene essential for extrinsic apoptosis? | CRISPR knockout in Jurkat or HeLa cells followed by TRAIL/FAS stimulation |
| Does a point mutation in CASP8 affect DISC formation? | CRISPR point mutation (e.g., catalytic dead) in cell lines |
| Does a disease-associated variant alter apoptotic signaling? | Knock-in of the variant using CRISPR in isogenic cell lines |
| Where does a protein localize during apoptosis? | Tagged knock-in (e.g., GFP) for live-cell imaging |
| Does overexpression of BCL-2 protect from apoptosis? | CRISPR overexpression (safe-harbor locus) in cancer cells |
| Which genes regulate apoptotic signaling in a genome-wide manner? | CRISPR library screening with apoptotic readouts |
How to Study the apoptotic signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantify apoptosis after gene knockout |
| Caspase-Glo assay | Caspase-3/7, -8, -9 activity | Determine pathway activation |
| Western blot | Cleavage of caspases and PARP | Validate apoptotic signaling |
| Immunoprecipitation | Protein-protein interactions (e.g., DISC) | Identify signaling complexes |
| CRISPR library screen | Gene essentiality for apoptosis | Discover novel regulators |
| Live-cell imaging | Mitochondrial permeabilization, caspase activation | Track apoptosis dynamics |
| RNA-seq | Transcriptional changes during apoptosis | Identify p53 target genes |
| Proteomics | Global protein cleavage and modification | Map apoptotic substrates |
Flow Cytometry and Annexin V Staining
Flow cytometry with Annexin V/propidium iodide staining is a standard method to quantify apoptotic cells. It measures phosphatidylserine externalization, an early apoptotic event. This method is widely used to assess the effect of genetic perturbations on apoptotic signaling.
Caspase Activity Assays
Caspase-3/7, -8, and -9 activity can be measured using fluorogenic or luminescent substrates. These assays determine which apoptotic pathway is activated and are useful for validating CRISPR knockout or point-mutation models.
Western Blotting and Immunoprecipitation
Western blotting detects cleavage of caspases and PARP, while immunoprecipitation can identify DISC components. These techniques are essential for mechanistic studies of apoptotic signaling.
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens with apoptotic readouts (e.g., cell viability under TRAIL treatment) identify novel regulators of apoptotic signaling. Bioinformatics analysis of screen data reveals enriched pathways and gene networks.
How CRISPR Can Be Used to Study GO:0097190 apoptotic signaling pathway
Knockout
CRISPR knockout is used to delete core apoptotic genes such as CASP8, FADD, or BAX to determine their requirement for apoptotic signaling. For example, CASP8 knockout cells are resistant to FAS-induced apoptosis, confirming its essential role.
Point Mutation
Point mutations can be introduced to study catalytic activity or post-translational modification sites. For instance, a catalytic-dead CASP8 mutant can be knocked into the endogenous locus to dissect its non-apoptotic functions.
Knock-in
Knock-in of disease-associated variants (e.g., TP53 R175H) or tagged proteins (e.g., GFP-BAX) allows functional and localization studies. This approach is valuable for understanding how mutations affect apoptotic signaling.
Overexpression
CRISPR-mediated overexpression (e.g., at the AAVS1 safe harbor locus) can be used to study the effect of increased levels of anti-apoptotic proteins like BCL-2 or pro-apoptotic proteins like BAX on apoptotic sensitivity.
How EDITGENE Supports apoptotic signaling pathway Research
Researchers studying apoptotic signaling pathway-related genes often need to determine whether a candidate gene is causally involved in apoptosis, how a specific mutation affects signaling, or where a protein localizes during cell death. EDITGENE provides tailored CRISPR services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for apoptotic signaling pathway research.
Frequently Asked Questions About apoptotic signaling pathway
What is the apoptotic signaling pathway (GO:0097190)?
It is the series of molecular signals that triggers apoptotic cell death, starting with signal reception and ending when the execution phase of apoptosis is triggered.
What genes are involved in the apoptotic signaling pathway?
Key genes include FAS, FASLG, TNFRSF10A/B, FADD, CASP8, CASP3, CASP9, BCL2, BAX, BAK, BID, and TP53.
What is the difference between extrinsic and intrinsic apoptotic signaling?
Extrinsic signaling is initiated by death receptors at the plasma membrane, while intrinsic signaling involves mitochondrial outer membrane permeabilization and is regulated by BCL-2 family proteins.
How is apoptotic signaling regulated?
It is regulated by transcriptional induction of BH3-only proteins, post-translational modifications, ubiquitination, and crosstalk with survival pathways such as PI3K/AKT and NF-kB.
What diseases are associated with dysregulated apoptotic signaling?
Cancer, neurodegeneration, autoimmune diseases, inflammatory disorders, and beta-thalassemia.
How can CRISPR be used to study apoptotic signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of apoptotic genes and variants.
What methods are used to measure apoptotic signaling?
Flow cytometry with Annexin V, caspase activity assays, Western blotting, immunoprecipitation, and CRISPR screens.
What is the role of caspases in apoptotic signaling?
Caspases are cysteine proteases that initiate and execute apoptosis; initiator caspases (8, 9) activate effector caspases (3, 7).
How does BCL-2 family regulate apoptosis?
Anti-apoptotic BCL-2 proteins inhibit BAX/BAK, while BH3-only proteins promote activation of BAX/BAK and mitochondrial permeabilization.
Can apoptotic signaling be targeted therapeutically?
Yes, BH3 mimetics and death receptor agonists are in clinical development for cancer and other diseases.
Conclusion
The apoptotic signaling pathway (GO:0097190) is a central biological process that governs cell fate decisions and is implicated in a wide range of human diseases. Understanding its molecular mechanisms through CRISPR-based models and functional assays is essential for developing targeted therapies. EDITGENE provides comprehensive services to support research on apoptotic signaling, from gene knockout to library screening and bioinformatics.
References
- 1. Raducka-Jaszul O et al.. 2020. Role of Extrinsic Apoptotic Signaling Pathway during Definitive Erythropoiesis in Normal Patients and in Patients with β-Thalassemia.. Int J Mol Sci 21(9) PMID: 32397135
- 2. Woo SM et al.. 2019. E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.. BMB Rep 52(2):119-126 PMID: 30638181
- 3. Chen X et al.. 2025. MicroRNA-204-5p Deficiency within the vmPFC Region Contributes to Neuroinflammation and Behavioral Disorders via the JAK2/STAT3 Signaling Pathway in Rats.. Adv Sci (Weinh) 12(10):e2403080 PMID: 39792918
- 4. Ryoo HD. 2012. Pro-apoptotic signaling pathway by CDK5 and MEKK1.. Cell Cycle 11(9):1746-7 PMID: 22510567
- 5. Chouit Z et al.. 2021. Potentiation of the apoptotic signaling pathway in both the striatum and hippocampus and neurobehavioral impairment in rats exposed chronically to a low-dose of cadmium.. Environ Sci Pollut Res Int 28(3):3307-3317 PMID: 32915453
- 6. Weng D et al.. 2025. Neutralization of IL-33 ameliorates septic myocardial injury through anti-inflammatory, anti-oxidative, and anti-apoptotic by regulating the NF-κB/STAT3/SOCS3 signaling pathway.. Biochem Pharmacol 237:116954 PMID: 40258576
- 7. Nonaka S et al.. 2017. Signaling pathway for phagocyte priming upon encounter with apoptotic cells.. J Biol Chem 292(19):8059-8072 PMID: 28325838
- 8. Meng T et al.. 2024. Dietary Chito-oligosaccharide attenuates LPS-challenged intestinal inflammation via regulating mitochondrial apoptotic and MAPK signaling pathway.. Int Immunopharmacol 126:111153 PMID: 37979451
